This webinar, presented by Chief Scientific Officer at Covance, Steve Anderson, PhD, will address the spectrum of immunotherapy development considerations and their implications for drug developers.
Please join us for an insightful discussion on these clinically and commercially relevant topics.
Contact the event managers listed below for more information about how you can participate at the The Role of Biomarkers and Companion / Complementary Diagnostics in Immuno-Oncology Trials.
|Conference/Event Dates:||10/05/2016 - 10/05/2016|
|Other Industries:||Business, Sciences|
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.